The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of response.

Cowey CL, Fielding JR, Rathmell WK
Urology. 2010 75 (5): 1108-13.e1

PMID: 19931124 · DOI:10.1016/j.urology.2009.06.105

MeSH Terms (19)

Antineoplastic Agents Benzenesulfonates Carcinoma, Renal Cell Female Humans Indoles Kidney Neoplasms Male Middle Aged Niacinamide Phenylurea Compounds Protein Kinase Inhibitors Pyridines Pyrroles Radiographic Image Enhancement Retrospective Studies Sorafenib Sunitinib Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: